Medios AG (OTCMKTS:MEDOF) Sees Significant Decrease in Short Interest

Medios AG (OTCMKTS:MEDOF) was the target of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 19,400 shares, a decline of 21.1% from the January 15th total of 24,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Medios Stock Performance

MEDOF stock opened at C$13.64 on Friday. Medios has a 52-week low of C$13.64 and a 52-week high of C$13.64. The business has a 50-day simple moving average of C$13.64 and a two-hundred day simple moving average of C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.